by Bacterial and viral specimen collection kits are used to collect and transport clinical specimens from patients for diagnosing various infectious diseases. These kits contain sterile collection swabs, transport media tubes, and other accessories to preserve the specimen integrity during transport to the laboratory for analysis. The products allow microbiological analysis of pathogens such as bacteria, viruses, and fungi from specimens such as blood, urine, swabs, and tissues. The need for early detection of infectious diseases is driving the demand for bacterial and viral specimen collection kits.
The Global bacterial and viral specimen collection market is estimated to be valued at US$ 29423.6 Mn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the bacterial and viral specimen collection market are Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd.
Rising adoption of molecular diagnostic techniques for infectious disease testing is creating significant opportunities for manufacturers in the Bacterial And Viral Specimen Collection Market Demand. Introduction of automated and molecular diagnostic platforms requires standardized specimen collection and transport solutions.
Geographic expansion through partnerships and mergers & acquisitions allow manufacturers to penetrate developing markets and cater to the growing testing needs. Entry of local players in Asia Pacific and Latin American regions has intensified competition.
Market drivers
Rising prevalence of infectious diseases globally is the major factor augmenting the market growth. Changing epidemiology and outbreaks of diseases such as pandemic influenza, HIV, tuberculosis, etc. have increased the demand for rapid diagnostics.
Market restrain
Stringent quality control and regulatory guidelines for validation of collection systems may hamper short-term growth. Significant infrastructure investments are required to ensure standardized protocols for specimen handling across the healthcare continuum in developing nations.
Segment Analysis
Swabs account for the largest share of the bacterial and viral specimen collection market owing to their non-invasive nature and convenience in sample collection. They are commonly used for collection of throat as well as nasal specimens which are most commonly collected in conditions like COVID-19 and influenza. Their low cost compared to other sample collection devices also makes them suitable for mass testing needs. Collection tubes hold the second largest share as they are required to store and transport the collected samples to laboratories for testing and diagnosis.
Global Analysis
North America dominates the global market due to large volume pneumonia, influenza and HIV testing in the region. Rising awareness levels for infectious disease diagnosis is also responsible for its large share. Asia Pacific is expected to witness highest growth rate during the forecast period attributed to growing medical tourism industry, increasing healthcare expenditure and rising number of novel pathogen outbreaks in developing countries of the region. Rapid economic development of China and India is also driving accelerated adoption of advanced diagnostic procedures in Asia Pacific. Initiatives by governments to increase healthcare access will further support regional market growth over next few years.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
Ravina Pandya
Ravina Pandya,Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. LinkedIn
